INmune Bio logo

INmune Bio

INMBNASDAQ

INmune Bio is a biotechnology company in the healthcare sector on NASDAQ, led by Raymond J. Tesi, with a market cap of $53.4M. As of Q3 2025, 18% of shares are held by 72 institutional investors, with BlackRock, Inc. as the largest holder at 4.46%.

Chief Executive OfficerRaymond J. Tesi
Market Cap$53.4M
Biotechnology
Healthcare
Employees17.0
Country
United States of America

Overview

Overview of institutional ownership in INMB as of Q3 2025 with a market cap of $55.0M

All Institutions

Institutions
72
Value Held
$9.6M
Shares Held
4.7M
Avg Position
$133.8K
Median Position
$24.9K

Hedge Funds

Hedge Funds
3
Value Held
$84.8K
Shares Held
41.0K
Avg Position
$28.3K
Median Position
$30.1K

Ownership Breakdown

Institutional (non-HF): 17.35%Institutional (non-HF)Hedge Funds: 0.15%Retail & Other: 82.49%Retail & Other
Institutional (non-HF)
17.35%
$9.5M
Hedge Funds
0.154%
$84.8K
Retail & Other
82.49%
$45.4M

Based on market cap of $55.0M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in INMB as of Q3 2025

InstitutionPosition Value
B
BlackRock, Inc.
Institution
$2.5M
0.00% of portfolio
$1.8M
0.00% of portfolio
$972.0K
0.00% of portfolio
$587.5K
0.00% of portfolio
$555.7K
0.00% of portfolio
$391.5K
0.00% of portfolio
$324.9K
0.00% of portfolio
UBS Group AG logo
UBS Group AG
Institution
$321.9K
0.00% of portfolio
$214.2K
0.04% of portfolio
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$156.7K
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for INMB in Q3 2025

Traded
$1.6M
Buyers
38
Sellers
43
Total Bought
+$1.4M
Total Sold
$3.1M
Avg Position
$102.5K

Biggest Buyers

InstitutionNet Bought
+$283.6K
+137.0K shares
+$169.9K
+82.1K shares
+$164.6K
+79.5K shares
+$127.1K
+61.4K shares
+$102.6K
+49.6K shares
+$79.9K
+38.6K shares
+$61.6K
+29.2K shares
+$59.1K
+28.5K shares
+$51.1K
+24.7K shares
AQR CAPITAL MANAGEMENT LLC logo
AQR CAPITAL MANAGEMENT LLC
Hedge FundMulti-Strategy
+$42.0K
+20.3K shares

Biggest Sellers

InstitutionNet Sold
UBS Group AG logo
UBS Group AG
Institution
$608.0K
293.7K shares
$411.8K
178.3K shares
$310.7K
248.5K shares
X
XTX Topco Ltd
Institution
$159.6K
77.1K shares
$134.6K
65.0K shares
$119.7K
57.8K shares
Scientech Research LLC logo
Scientech Research LLC
Hedge FundMarket Neutral
$105.7K
45.7K shares
L
$99.7K
43.2K shares
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
$98.4K
42.6K shares
$92.9K
40.2K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited INMB in Q3 2025

New Positions
10
New Value
$188.6K
Exited Positions
22
Exited Value
$1.7M

New Positions

InstitutionPosition Value
AQR CAPITAL MANAGEMENT LLC logo
AQR CAPITAL MANAGEMENT LLC
Hedge FundMulti-Strategy
$42.0K
20.3K shares
L
LMR Partners LLP
Institution
$34.4K
16.6K shares
$30.0K
14.5K shares
$28.8K
13.9K shares
$24.3K
11.7K shares
$22.3K
10.8K shares
$4.1K
2.0K shares
$1.3K
619.0 shares
$1.0K
490.0 shares
$327.0
158.0 shares

Exited Positions

InstitutionPrevious Position
$411.8K
178.3K shares
$310.7K
248.5K shares
Scientech Research LLC logo
Scientech Research LLC
Hedge FundMarket Neutral
$105.7K
45.7K shares
L
$99.7K
43.2K shares
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
$98.4K
42.6K shares
$92.9K
40.2K shares
G
$82.3K
35.6K shares
TWO SIGMA INVESTMENTS LLC logo
TWO SIGMA INVESTMENTS LLC
Hedge FundMulti-Strategy
$82.2K
35.6K shares
$61.8K
26.7K shares
H
$60.4K
28.1K shares

Options Activity

Institutions with the largest Call and Put options positions in INMB as of Q3 2025

Call Positions
7
Call Value
$642.2K
Put Positions
12
Put Value
$769.5K

Call Positions

InstitutionPosition Value
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$415.2K
2.0K contracts
$199.1K
962.0 contracts
$27.9K
132.0 contracts
Caption Management, LLC logo
Caption Management, LLC
Hedge FundLong/Short
-
- contracts
-
- contracts
-
- contracts
M
MASTERS CAPITAL MANAGEMENT LLC
Hedge FundLong/Short
-
- contracts

Put Positions

InstitutionPosition Value
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$364.5K
1.8K contracts
$322.1K
1.6K contracts
$70.3K
333.0 contracts
OZ MANAGEMENT LP logo
OZ MANAGEMENT LP
Hedge FundMulti-Strategy
$12.6K
61.0 contracts
Affinity Asset Advisors, LLC logo
Affinity Asset Advisors, LLC
Hedge FundLong/Short
-
- contracts
ORBIMED ADVISORS LLC logo
ORBIMED ADVISORS LLC
Hedge FundSector
-
- contracts
A
ADAR1 Capital Management, LLC
Hedge FundLong/Short
-
- contracts
Caption Management, LLC logo
Caption Management, LLC
Hedge FundLong/Short
-
- contracts
M
MYDA Advisors LLC
Hedge FundLong/Short
-
- contracts
L
LMR Partners LLP
Institution
-
- contracts

Most Committed Institutions

Institutions with INMB as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
0.04%
$214.2K
0.01%
$51.8K
X
XTX Topco Ltd
Institution
0.01%
$100.9K
0.00%
$79.9K
0.00%
$61.6K
0.00%
$84.8K
0.00%
$30.0K
0.00%
$28.8K
L
LMR Partners LLP
Institution
0.00%
$34.4K
0.00%
$25.9K

Hedge Fund Spotlight

Discover hedge funds investing in INMB

AQR CAPITAL MANAGEMENT LLC logo
AQR CAPITAL MANAGEMENT LLC
Hedge FundMulti-Strategy
Portfolio ManagerDavid Gary Kabiller
Portfolio Value
$156.17B
Positions
3,453
Last Reported
Q3 2025
AddressGreenwich, CT
Sector Allocation
Technology: 25.40%TechnologyFinancial Services: 14.40%Financial ServicesHealthcare: 11.90%HealthcareConsumer Cyclical: 11.60%Consumer CyclicalIndustrials: 11.60%IndustrialsCommunication Services: 5.20%Consumer Defensive: 5.10%Energy: 3.20%Utilities: 3.00%Real Estate: 2.50%Basic Materials: 2.40%ETF: 2.40%
INmune Bio logo

Position in INmune Bio

Market Value
$42.0K
Shares Held
20.3K
Portfolio Weight
0.00%
Owned Since
2025-Q3
Top HoldingSectorMarket ValueWeight
1
Nvidia logo
Nvidia
NVDA
Semiconductors
Technology
$4.1B2.62%
Software - Infrastructure
Technology
$3.2B2.05%
3
Apple logo
Apple
AAPL
Consumer Electronics
Technology
$2.8B1.76%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.